Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $1.06 Trillion
  • Q3 2025

Adar1 Capital Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.06 Trillion distributed in 220 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Abivax Sa with a value of $115B, Keros Therapeutics, Inc. with a value of $85.3B, Protagonist Therapeutics, Inc with a value of $65.7B, Roivant Sciences Ltd. with a value of $50.6B, and Ea Series Trust with a value of $38.4B.

Examining the 13F form we can see an increase of $412B in the current position value, from $652B to 1.06T.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.06 Trillion
Healthcare: $648 Billion
ETFs: $83.7 Billion
Communication Services: $996 Million
Consumer Cyclical: $989 Million
Technology: $689 Million
Financial Services: $531 Million
Basic Materials: $312 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$795M
$851 Million 0.08% of portfolio
34,124
Q2 2025 New
Tectonic Therapeutic Inc
-
$879 Million 0.08% of portfolio
-
Q3 2025 Reduced 23.81%
Anteris Technologies Global
-
$889 Million 0.08% of portfolio
-
Q3 2025 Reduced 62.82%
$600M
$872 Million 0.08% of portfolio
119,067
Q3 2025 Added 3.7%
$971B
$763 Million 0.07% of portfolio
1,000
Q3 2025 Added 100.0%
Lite Strategy Inc
-
$708 Million 0.07% of portfolio
-
Q3 2025 New
$2.34B
$748 Million 0.07% of portfolio
51,516
Q3 2025 Added 44.24%
$168M
$710 Million 0.07% of portfolio
373,682
Q3 2025 New
$146M
$761 Million 0.07% of portfolio
235,689
Q3 2025 Reduced 0.81%
$1.95B
$748 Million 0.07% of portfolio
20,087
Q3 2025 Reduced 49.37%
$553M
$698 Million 0.07% of portfolio
35,000
Q3 2025 Added 250.0%
$562M
$704 Million 0.07% of portfolio
82,591
Q3 2025 Reduced 35.86%
$0
$595 Million 0.06% of portfolio
59,230
Q3 2025 New
Maze Therapeutics Inc
-
$675 Million 0.06% of portfolio
-
Q3 2025 New
$1.44B
$649 Million 0.06% of portfolio
40,000
Q2 2025 Added 100.0%
$423M
$625 Million 0.06% of portfolio
456,176
Q3 2025 Added 3.4%
$2.41B
$689 Million 0.06% of portfolio
14,418
Q3 2025 New
$9.88B
$689 Million 0.06% of portfolio
10,000
Q3 2025 New
$575M
$505 Million 0.05% of portfolio
42,900
Q3 2025 Reduced 32.36%
$4.72B
$531 Million 0.05% of portfolio
10,000
Q3 2025 New
Globa Terra Acquisition Cor
-
$509 Million 0.05% of portfolio
-
Q3 2025 New
$255M
$559 Million 0.05% of portfolio
212,531
Q3 2025 Reduced 6.47%
$1.54B
$544 Million 0.05% of portfolio
20,000
Q3 2025 New
$0
$503 Million 0.05% of portfolio
10,000
Q3 2024 Reduced 81.13%
Assembly Biosciences Inc
-
$485 Million 0.05% of portfolio
-
Q3 2025 New
Spyre Therapeutics Inc
-
$571 Million 0.05% of portfolio
-
Q2 2025 Added 126.51%
$749M
$487 Million 0.05% of portfolio
55,000
Q3 2025 Added 60.35%
American Exceptionalism Acqu
-
$547 Million 0.05% of portfolio
-
Q3 2025 New
Kezar Life Sciences Inc
-
$487 Million 0.05% of portfolio
-
Q3 2025 Reduced 15.22%
Neurogene Inc
-
$531 Million 0.05% of portfolio
-
Q3 2025 Added 3.4%
Lenz Therapeutics Inc
-
$541 Million 0.05% of portfolio
-
Q3 2025 New
Avalo Therapeutics Inc
-
$412 Million 0.04% of portfolio
-
Q3 2025 Reduced 69.07%
Vistagen Therapeutics Inc
-
$401 Million 0.04% of portfolio
-
Q3 2025 Reduced 73.13%
Tenax Therapeutics Inc
-
$407 Million 0.04% of portfolio
-
Q3 2025 Reduced 65.65%
$2.23B
$453 Million 0.04% of portfolio
20,000
Q3 2025 Added 17.65%
$1.37B
$433 Million 0.04% of portfolio
20,000
Q3 2025 Reduced 50.0%
Structure Therapeutics Inc
-
$426 Million 0.04% of portfolio
-
Q3 2025 Added 1.33%
Intelligent Bio Solutions In
-
$435 Million 0.04% of portfolio
-
Q3 2025 New
Oruka Therapeutics Inc
-
$401 Million 0.04% of portfolio
-
Q3 2025 Reduced 85.4%
$1.19B
$439 Million 0.04% of portfolio
34,000
Q3 2025 New
$975M
$476 Million 0.04% of portfolio
37,663
Q3 2025 Added 63.3%
$2.49B
$445 Million 0.04% of portfolio
6,000
Q3 2025 New
$9.65B
$375 Million 0.04% of portfolio
6,000
Q3 2025 New
Kiora Pharmaceuticals Inc
-
$467 Million 0.04% of portfolio
-
Q3 2025 Added 0.5%
$603M
$288 Million 0.03% of portfolio
31,200
Q2 2025 Added 47.17%
$109M
$268 Million 0.03% of portfolio
133,530
Q3 2025 Added 11.91%
$18.5M
$340 Million 0.03% of portfolio
351,094
Q4 2024 Reduced 6.08%
$2.32B
$271 Million 0.03% of portfolio
9,000
Q3 2025 New
$46.1B
$350 Million 0.03% of portfolio
10,000
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 220
  • Current Value $1.06 Trillion
  • Prior Value $652 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 47 stocks
  • Additional Purchases 67 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 52 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email